罗孔嘉 - 中山大学 - 肿瘤防治中心

个人简介

学习及工作经历 Degree-Granting Education 　　2009.09-2012.07,中山大学肿瘤防治中心胸科，肿瘤学（胸外科），博士研究生　　2006.09-2009.07,中山大学肿瘤防治中心胸科，肿瘤学（胸外科），硕士研究生　　2001.09-2006.07, 中山大学肿瘤防治中心胸科，临床医学，本科 Postgraduate Training 　　2013.12-Present, 中山大学肿瘤防治中心胸科，主治医师　　2012.08-2013.11,中山大学肿瘤防治中心胸科，住院医师

研究领域

以内镜外科技术为基础的早期食管癌、早期肺癌以及胸膜疾病的诊断及治疗

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1. Luo KJ, Hu Y, Wen J, et al. CyclinD1, p53, E-cadherin, and VEGF discordant expression in paired regional metastatic lymph nodes of esophageal squamous cell carcinoma: a tissue array analysis. J Surg Oncol 2011; 104(3):236-43. 　　2. Luo KJ, Wen J, Xie X, et al. Prognostic Relevance of Id-1 Expression in Patients with Resectable Esophageal Squamous Cell Carcinoma: a Tissue Array Analysis on 407 Cases. Ann Thorac Surg. 2012 May;93(5):1682-8. 　　3. Wen J, Luo KJ (Co-author) , Hu Y, et al. Metastatic Lymph Node CHIP Expression is a Potential Prognostic Marker for Resected Esophageal Squamous Cell Carcinoma Patients. Ann Surg Oncol. 2013 Feb 22. 　　4. Luo KJ, Fu JH, Hu Y, et al. Efficacy of surgical resection of left and right transthoracic approaches for middle thoracic esophageal squamous cell carcinoma. Ai Zheng 2009; 28(12):1260-4. 　　5. Wen J, Hu Y, Luo KJ, et al.: Positive transforming growth factor-beta activated kinase-1 expression has an unfavorable impact on survival in T3N1-3M0 esophageal squamous cell carcinomas. Ann Thorac Surg 2013;95:285-290. 　　6. Zhang SS, Yang H, Luo KJ(Co-author), et al. The impact of body mass index on complication and survival in resected oesophageal cancer: a clinical-based cohort and meta-analysis. Br J Cancer 2013; 109(11):2894-903. 　　7. Wang XS, Luo KJ (Co-author), Bella AE, et al. Caspase-3 expression in metastatic lymph nodes of esophageal squamous cell carcinoma is prognostic of survival. World J Gastroenterol 2014; 20(15):4414-20.